Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Author:

Gao Yan12ORCID,Yan Liming1ORCID,Huang Yucen1,Liu Fengjiang2ORCID,Zhao Yao2ORCID,Cao Lin3,Wang Tao1ORCID,Sun Qianqian2ORCID,Ming Zhenhua4,Zhang Lianqi1,Ge Ji1,Zheng Litao1,Zhang Ying1,Wang Haofeng25ORCID,Zhu Yan2,Zhu Chen2,Hu Tianyu2ORCID,Hua Tian2,Zhang Bing2ORCID,Yang Xiuna2,Li Jun2ORCID,Yang Haitao2ORCID,Liu Zhijie2,Xu Wenqing2,Guddat Luke W.6ORCID,Wang Quan2ORCID,Lou Zhiyong1ORCID,Rao Zihe1237ORCID

Affiliation:

1. Laboratory of Structural Biology, School of Life Sciences, and School of Medicine, Tsinghua University, Beijing, China.

2. Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, China.

3. State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, and College of Pharmacy, Nankai University, Tianjin, China.

4. State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, College of Life Science and Technology, Guangxi University, Nanning, China.

5. School of Life Sciences, Tianjin University, Tianjin, China.

6. School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.

7. National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, CAS, Beijing, China.

Abstract

The COVID-19 RNA-synthesizing machine Many in the scientific community have mobilized to understand the virus that is causing the global coronavirus disease 2019 (COVID-19) pandemic. Gao et al. focused on a complex that plays a key role in the replication and transcription cycle of the virus. They used cryo–electron microscopy to determine a 2.9-angstrom-resolution structure of the RNA-dependent RNA polymerase nsp12, which catalyzes the synthesis of viral RNA, in complex with two cofactors, nsp7 and nsp8. nsp12 is a target for nucleotide analog antiviral inhibitors such as remdesivir, and the structure may provide a basis for designing new antiviral therapeutics. Science , this issue p. 779

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Strategic Priority Research Program of the Chinese Academy of Sciences

National Program on Key Research Project of China

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 1352 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics;European Journal of Medicinal Chemistry Reports;2024-12

2. Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates;Pathology - Research and Practice;2024-11

3. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

4. Proteomic strategies to interrogate the Fe-S proteome;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

5. Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics;International Journal of Biological Macromolecules;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3